<code id='44142FEDA8'></code><style id='44142FEDA8'></style>
    • <acronym id='44142FEDA8'></acronym>
      <center id='44142FEDA8'><center id='44142FEDA8'><tfoot id='44142FEDA8'></tfoot></center><abbr id='44142FEDA8'><dir id='44142FEDA8'><tfoot id='44142FEDA8'></tfoot><noframes id='44142FEDA8'>

    • <optgroup id='44142FEDA8'><strike id='44142FEDA8'><sup id='44142FEDA8'></sup></strike><code id='44142FEDA8'></code></optgroup>
        1. <b id='44142FEDA8'><label id='44142FEDA8'><select id='44142FEDA8'><dt id='44142FEDA8'><span id='44142FEDA8'></span></dt></select></label></b><u id='44142FEDA8'></u>
          <i id='44142FEDA8'><strike id='44142FEDA8'><tt id='44142FEDA8'><pre id='44142FEDA8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:962
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health
          Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

          John-ArneRøttingenistheheadoftheWellcomeTrust,oneoftheworld’stopprivatefundersofbiomedicalresearch.I

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Criminal prosecution for violating HIPAA: an emerging threat

          BRENDANSMIALOWSKI/AFP/GettyImagesTheterm“HIPAAviolation”canconjureupimagesoflarge-scaledatabreaches.